Michela Stucchi is responsible for the Business Development activities of IMAX Discovery GmbH since June 2019. Prior to that, she was Head of the Screening Technologies group at Axxam. In that role, she was in charge of the management and coordination of the scientific activities related to HTS, compound profiling & hit to lead, data analysis, automation and compound management.
From 2001 until 2006 she was senior scientist in the Enabling Technologies group at Axxam, taking care of the development of cell-based high-throughput screening assays.
Before joining Axxam, she was a scientist at the Bayer Research Center (Milan, Italy) dedicated to assay development. Michela holds a degree in Biology from the University of Milano.